COVID-19 Patients Treated With this Drug Recommended By Donald Trump Likely To Die – Study

COVID-19 Patients Treated With this Drug Recommended By US President Likely To Die - Study
A panel of medical experts from the National Institutes of Health on Tuesday recommended against using the combination of hydroxychloroquine and azithromycin to treat the coronavirus outside clinical trials, undercutting President Donald Trump’s initial claims that the drugs were a promising treatment for the disease, according to a report by Forbes.
The study of 308 patients in the United States found that 97 patients who took hydroxychloroquine had a death rate of 27.8 percent, while 158 patients who did not receive the drug had an 11.4% death rate.
It also found that about 22 percent of those taking the drug in addition to azithromycin also died. However, the difference between this category and those under usual care was not considered “large enough” to rule out other factors that could have affected their recovery.
The study was conducted at the US Veterans Health Administration medical centers and funded by the National Institutes of Health and the University of Virginia.
The authors of the research, published here, said it had not been certified by peer review, meaning the findings cannot guide clinical practice yet.
The findings state: “An association of increased overall mortality was identified in patients treated with hydroxychloroquine alone.
“These findings highlight the importance of awaiting the results of ongoing prospective, randomized, controlled studies before widespread adoption of these drugs.
“In this study, we found no evidence that the use of hydroxychloroquine, either with or without azithromycin, reduced the risk of mechanical ventilation in patients hospitalized with COVID-19.”
The latest study might be the largest so far on the use of hydroxychloroquine, which the US President Donald Trump has often touted as a “game-changer. “
TheCable had reported that a similar study about the anti-malaria drug conducted in China found that it does not speed up the recovery of COVID-19 patients.
But there have been success stories about the drug, including its reported use in treating at least 500 patients in a US town.
The World Health Organisation (WHO) has often warned against the use of untested drugs — or vaccines — in managing COVID-19 patients.
At least 70 vaccines are being developed for the disease, while some countries such as the United Kingdom and Germany have approved human trials for some

How You Can Get Updates Regularly 
✔️ Enter Your Email To subscribe 🇳🇬

✔️ Like/Follow Our  Facebook Page 
✔️ Join our Telegram Channel 

2021 Massive Recruitment At First Bank Of Nigeria Limited For Graduates

Recent Posts

Recent Jobs

From Ejes Gist Nigeria

The views expressed in this article are the writer’s opinion, they do not reflect the views of the Publisher of EJES GIST NIGERIA. Please report any fake news , misinformation or defamatory statements to

For Publication and Advert Booking Call +2347033247217  or email


Most Trending Post

Latest News


Please enter your comment!
Please enter your name here

seventeen + 19 =

This site uses Akismet to reduce spam. Learn how your comment data is processed.